Want to see SG:8YY full AI Analyst Report?
Biolidics Ltd. (8YY) Financial Statements
Biolidics Ltd. Financial Overview
Biolidics Ltd.'s market cap is currently $41.60M. The company's EPS TTM is $-0.00; its P/E ratio is -12.63; Biolidics Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.26M | $ 784.00K | $ 277.00K | $ 2.49M | $ 2.31M |
| Gross Profit | $ 1.94M | $ 187.00K | $ 146.00K | $ 1.16M | $ 483.00K |
| Operating Income | $ -3.22M | $ -1.70M | $ -996.00K | $ -3.04M | $ -3.31M |
| EBITDA | $ -3.65M | $ -3.03M | $ -1.16M | $ -8.50M | $ -4.58M |
| Net Income | $ -3.96M | $ -3.43M | $ -2.49M | $ -9.37M | $ -5.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 557.00K | $ 295.00K | $ 183.00K | $ 5.03M | $ 3.96M |
| Total Assets | $ 5.08M | $ 4.67M | $ 682.00K | $ 6.09M | $ 11.42M |
| Total Debt | $ 2.41M | $ 1.75M | $ 2.02M | $ 3.01M | $ 4.25M |
| Net Debt | $ 1.86M | $ 1.46M | $ 1.84M | $ -2.02M | $ 289.00K |
| Total Liabilities | $ 3.56M | $ 2.94M | $ 2.67M | $ 7.78M | $ 9.09M |
| Stockholders' Equity | $ 1.53M | $ 1.73M | $ -1.99M | $ -1.69M | $ 2.33M |
| Cash Flow | |||||
| Free Cash Flow | $ -360.00K | $ -2.32M | $ -1.97M | $ -3.16M | $ -5.20M |
| Operating Cash Flow | $ -360.00K | $ -2.31M | $ -1.97M | $ -3.06M | $ -4.64M |
| Investing Cash Flow | $ 0.00 | $ -5.00K | $ -2.69M | $ 5.00K | $ -860.00K |
| Financing Cash Flow | $ 623.00K | $ 2.36M | $ -200.00K | $ 4.18M | $ -1.15M |
Currency in SGD